Teladoc stock surges after earnings as losses narrow

Shares of Teladoc Health Inc. were up about 13% in after-hours trading Wednesday after the telemedicine company posted a narrower loss than analysts were anticipating for its latest quarter, while sli...

Teladoc Stock Sinks on Wider Loss and Weak Guidance

Teladoc Health was falling more than 23% in premarket trading Thursday after the remote healthcare provider posted a wider-than-expected quarterly loss after recording a $3 billion impairment charge. ...

Teladoc loses $3 billion in three months, stock plummets 24%

Shares of Teladoc Health Inc. plunged more than 24% in after-hours trading Thursday after the telehealth company took another multibillion-dollar impairment charge, helping to bring its total losses f...

Carvana, Robinhood and Teladoc Stock Give Way to Old-School Rivals. Here’s When It Might Be Safe to Buy.

Text size Carvana’s stock has fallen nearly 80% in the past 12 months. Mark Ralston/AFP/Getty Images It’s new school versus old school, and the new school doesn’t stand a chance. No, we’re not talking...

Cathie Wood’s ARK Bet Big on Tumbling Teladoc. These Funds Did Too.

Text size A Teladoc member visits virtually with a doctor. Courtesy of Teledoc Cathie Wood’s ARK Invest and other institutional investors were slated to take a steep hit as shares of Teladoc Health pl...

Teladoc stock plunges more than 30% after earnings outlook slashed, massive impairment charge

Shares of Teladoc Health Inc. were slammed in after-hours trading Wednesday, after the telemedicine company took an impairment charge of more than $6.5 billion and slashed its full-year outlook. Telad...

Cathie Wood’s Flagship Fund Is Down 45% This Year. Money Is Still Flowing In.

Cathie Wood’s ARK Innovation exchange-traded fund keeps falling, but investors aren’t jumping ship. Shares of the popular ETF, which is known by its ticker ARKK, have declined 45% so far in 2022—inclu...

Teladoc Stock Has Tumbled. Goldman Sachs Sees a Major Recovery.

Text size Teladoc stock is set for a big comeback, says Goldman Sachs. Courtesy of Teladoc Teladoc Health stock has shed half its value in the past six months. An analyst at Goldman Sachs says it’s ti...